$13.07
+0.11 (+0.85%)
Performance
1D
—
1W
—
1M
—
3M
-82.07%
6M
-81.51%
1Y
-55.44%
YTD
-81.87%
Open$12.88
Previous Close$12.96
Day High$13.19
Day Low$12.84
52W High$73.06
52W Low$11.95
Volume—
Avg Volume245.3K
Market Cap221.80M
P/E Ratio—
EPS$-2.89
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$72.38
Below
SMA 200
$51.57
Below
RSI (14)
65.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
5 analysts
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 18.46M | 11.65M | 2.36B |
| Net Income | -49,085,050 | -27,882,191 | -651,372,475 |
| Profit Margin | -265.9% | -252.6% | -27.6% |
| EBITDA | -48,905,164 | -29,323,343 | -865,943,607 |
| Free Cash Flow | — | — | -400,975,764 |
| Rev Growth | +58.4% | +58.4% | +6.9% |
| Debt/Equity | — | — | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |